Figure 2From: Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma (A) 8 AM plasma cortisol levels and (B) 12-hour urinary free cortisol levels adjusted for creatinine (UCCR) at baseline and endpoint. Endpoint was defined as the measurement taken closest to the last day of study treatment. Bars indicate means + standard deviations. BID = twice daily; BDP = beclomethasone dipropionate; MF-DPI = mometasone furoate administered via a dry powder inhaler; QD AM = once daily in the morning.Back to article page